96 related articles for article (PubMed ID: 8640797)
1. Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2.
Cortazzo M; Schor NF
Cancer Res; 1996 Mar; 56(6):1199-203. PubMed ID: 8640797
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2.
Mi Z; Hong B; Mirnics ZK; Tyurina YY; Kagan VE; Liang Y; Schor NF
Cancer Chemother Pharmacol; 2006 Feb; 57(3):357-67. PubMed ID: 16001169
[TBL] [Abstract][Full Text] [Related]
3. Cell line dependence of Bcl-2-induced alteration of glutathione handling.
Schor NF; Rudin CM; Hartman AR; Thompson CB; Tyurina YY; Kagan VE
Oncogene; 2000 Jan; 19(3):472-6. PubMed ID: 10656697
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner.
Prokop A; Wrasidlo W; Lode H; Herold R; Lang F; Henze G; Dörken B; Wieder T; Daniel PT
Oncogene; 2003 Dec; 22(57):9107-20. PubMed ID: 14647446
[TBL] [Abstract][Full Text] [Related]
5. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.
Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K
Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044
[TBL] [Abstract][Full Text] [Related]
6. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
Mc Gee MM; Greene LM; Ledwidge S; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2004 Sep; 310(3):1084-95. PubMed ID: 15143129
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination.
Chanvorachote P; Nimmannit U; Stehlik C; Wang L; Jiang BH; Ongpipatanakul B; Rojanasakul Y
Cancer Res; 2006 Jun; 66(12):6353-60. PubMed ID: 16778213
[TBL] [Abstract][Full Text] [Related]
8. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
9. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Rudin CM; Yang Z; Schumaker LM; VanderWeele DJ; Newkirk K; Egorin MJ; Zuhowski EG; Cullen KJ
Cancer Res; 2003 Jan; 63(2):312-8. PubMed ID: 12543781
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.
Hartsell TL; Yalowich JC; Ritke MK; Martinez AJ; Schor NF
J Pharmacol Exp Ther; 1995 Oct; 275(1):479-85. PubMed ID: 7562588
[TBL] [Abstract][Full Text] [Related]
12. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
Liu HZ; Li DD; Zhen YS; Shao RG
Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cells.
Del Bello B; Valentini MA; Zunino F; Comporti M; Maellaro E
Oncogene; 2001 Jul; 20(33):4591-5. PubMed ID: 11494156
[TBL] [Abstract][Full Text] [Related]
14. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
15. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
16. EAT/mcl-1 expression in the human embryonal carcinoma cells undergoing differentiation or apoptosis.
Sano M; Umezawa A; Abe H; Akatsuka A; Nonaka S; Shimizu H; Fukuma M; Hata J
Exp Cell Res; 2001 May; 266(1):114-25. PubMed ID: 11339830
[TBL] [Abstract][Full Text] [Related]
17. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells.
Wang L; Chanvorachote P; Toledo D; Stehlik C; Mercer RR; Castranova V; Rojanasakul Y
Mol Pharmacol; 2008 Jan; 73(1):119-27. PubMed ID: 17911532
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.
Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G
Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in the absence of caspase 3.
Liang Y; Yan C; Schor NF
Oncogene; 2001 Oct; 20(45):6570-8. PubMed ID: 11641782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
